Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1 (Fig
Tamura et al., 2010)
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Of course, individual results depend on factors like diet, exercise, and starting weight
doi: 10.1016/j.lwt.2018.07.007 72 ShahABBaiseitovaAZahoorMAhmadIIkramMBakhshAet al
CLEAN SUPPLEMENTS & CLEAN INGREDIENTS - Hashimoto's Ab Rx is gluten-free, dairy-free, soy-free, GMO-free, and free of artificial colors, sweeteners, and preservatives.